Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hulka is an Italian pharmaceutical and dermocosmetic company founded in 1996 by Dr. Vittorio Panin. The company specializes in the research and development of products based on Vitamin E (tocopherol) for the treatment of sensitive, allergic, or reactive skin. Its flagship brand, VEA, includes a wide range of formulations such as oils, creams, and sprays that are characterized by being free of preservatives, fragrances, and dyes. Hulka operates primarily in the European market, providing dermatological solutions for pediatrics, gynecology, and general skin care. The company is recognized for its commitment to high-purity ingredients and hypoallergenic formulations suitable for all skin types.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hulka.